Model-informed Precision Dosing of Vancomycin in Adults
Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The overall objective of this project is to investigate the utility of model-informed
precision dosing (MIPD) of vancomycin in non-critically ill adults. This evaluation includes
a comparison with the more standard approach on clinical and patient-oriented measures.